|
°æÈñ´ëÇб³º´¿ø(º´¿øÀå ±è°Ç½Ä)Àº È£Èí±â¾Ë·¹¸£±â³»°ú À̽ÂÇö ±³¼ö°¡ Áö³ ´Þ 22ÀÏ Æòâ Ä˽ÌÅÏ ÇöóÀÚ È£ÅÚ¿¡¼ ÁøÇàµÈ ´ëÇÑÆó¾ÏÇÐȸ Çмú´ëȸ¿¡¼ Çмú»óÀ» ¼ö»óÇß´Ù. ´ëÇÑÆó¾ÏÇÐȸ Çмú»óÀº Áö³ 1³â µ¿¾È ´ëÇѾÏÇÐȸ °ø½Ä ÇмúÁö¿¡ ¹ßÇ¥µÈ Æó¾Ï °ü·Ã ³í¹® Áß °¡Àå ¿ì¼öÇÑ ³í¹®À» ¼±Á¤ÇØ ¼ö»óÇÑ´Ù. ÀÌ ±³¼öÀÇ ³í¹® ÁÖÁ¦´Â ‘¹é±Ý±â¹Ý Ç×¾ÏÄ¡·á¸¦ ¹ÞÀº ȯÀÚ¿¡¼ ¿¹ÈÄ ¿¹ÃøÀÎÀڷμ Romo1ÀÇ ÀÓ»óÀû ÀÇÀÇ (Reactive Oxygen Species Modulator 1 (Romo1) Predicts Poor Outcomes in Advanced Non-small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy)’ÀÌ´Ù. |